Page 22 - Pharma Sector

CDSCO cracks whip on drug manufacturing units over quality lapses

Shuts down 36% of facilities for failing to meet quality standards

Pharma industry body mulling policy framework to guide cos on cybercrime

The Indian pharma companies are better off in terms of facing cyber-attacks now as compared to a few years ago

Indian pharma sites outpace global standards in USFDA inspections for 2023

The USFDA categorised 13 per cent (19 out of 145 inspections) of Indian facilities as 'Official Action Indication'(OAI), which is lower than the global average of 15 per cent OAIs

Alkem Labs shares surge 5% on USFDA's VAI status for Baddi facility

Shares of Alkem Labs gain up to 4.77 per cent at Rs 5,250.30 per share on the BSE in Tuesday's intraday trade

Govt may overhaul PLI schemes: Quarterly incentive payments on the table

In a bid to cut the delay in processing incentive claims, the government is looking at switching to a quarterly disbursement of incentives

Biocon searches for partner to test generic Wegovy, Ozempic in China

Biocon's generics would join at least 15 other generics or biosimilars in development by Chinese drugmakers ahead of an expiry of patent protection on semaglutide

Wanbury surges 5% after USFDA issues Zero observations for Patalganga site

At 9:55 AM, the shares were off highs, trading 2.25 per cent higher at Rs 163.95 per share. In comparison, BSE Sensex was trading 0.16 per cent lower at 77,211.40 levels.

Nepal's drug regulator bans sale of Indian antibiotic over quality issues

Zydus Lifesciences said the reports were 'misleading and erroneous'

Dr Reddy's Laboratories, Warburg Pincus, EQT frontrunners to buy BSV

Advent looking to exit 4 years after it picked up majority stake in biopharma firm

Cipla to invest additional 3 mn euro in mRNA technology company Ethris

The aim is to accelerate Cipla's entry into the mRNA space and deliver innovative mRNA-based therapies, particularly targeting respiratory treatments, to patients in emerging markets

Approval timelines for clinical trial applications back to pre-Covid days

During pandemic, process was faster and nods for Covid-19 trials came in 30 days

Suven Pharma stock rises 6% on nod to acquire Sapala Organics for Rs 230 cr

The surge came after Suven Pharmaceuticals said that it has entered into a definitive agreement to acquire a controlling stake of Sapala Organic for Rs 229.5 crore, in an all cash deal

Venus Remedies up 8% on order win from UNICEF for bacterial infection drug

The uptick in stock price came after the company announced that it has secured an award for its antibiotic product, Ceftriaxone 1 gm, from UNICEF

Torrent Pharma slips 3% after USFDA issues 5 observations for Indrad Unit

The fall came after the United States Food and Drug Administration (USFDA) issued a Form 483 with five observations for the Indrad unit

Pharma's eco pill: Sustainable packaging as new prescription for planet

Merck also revealed that they are investing in renewable energy sources, and half of their Mumbai facility's energy is now sourced from solar panels

IOL Chemicals share price up 6% on bagging CEP certificate for Pantoprazole

Pantoprazole is used for heartburn, acid reflux and gastro-oesophageal reflux disease (GORD)

Weather changes drove Indian pharma market growth to 5.2% in May

Anti-infectives, respiratory therapy areas clock double-digit value growth

Pharma companies step up use of advanced technologies to improve processes

Industry is using AI and digital tools to improve processes and help patients

Dr Reddy's Laboratories eyes acquisitions to drive growth in India

The share of chronic has been steadily rising in the Rs 2 lakh crore domestic pharma market- from 36.4 percent in January 2022 to 38.1 percent in January 2024

Torrent Pharmaceuticals enters into patent licensing agreement with Takeda

Torrent will market Vonoprazan under its own trademark, Kabvie